INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on December 2, 2025. INVO Fertility, Inc., a Nevada corporation, announced the completion of a private placement of securities with an institutional investor to raise capital for strategic acquisitions, debt repayment, and general corporate purposes.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $4,000,000 raised from the sale of securities.
- Securities Issued:
- 235,000 shares of Common Stock.
- Pre-Funded Warrants to purchase 2,131,864 shares of Common Stock (exercise price: $0.0001).
- Common Warrants to purchase 4,733,728 shares of Common Stock (exercise price: $1.69).
- Placement Agent Fees: 8.0% of gross proceeds plus warrants to purchase 118,343 shares (exercise price: $2.1125) and reimbursement of expenses up to $50,000.
- Use of Proceeds:
- Up to $300,000 for the purchase price of Family Beginnings, P.C.
- Up to $75,000 for expenses related to the Family Beginnings acquisition.
- Up to $938,000 for outstanding debt obligations.
- Balance for working capital and general corporate purposes.
Material Changes and Agreements
The Company entered into a Securities Purchase Agreement, a Placement Agency Agreement with Maxim Group LLC, and a Registration Rights Agreement. The transaction includes a 60-day lock-up period restricting the issuance of new equity or filing of registration statements, and a six-month restriction on Variable Rate Transactions.
Outlook, Risks, and Contingencies
The filing indicates a strategic move to acquire Family Beginnings, P.C., suggesting an expansion of the Company's service footprint. The issuance of significant warrant coverage (Pre-Funded and Common Warrants) introduces potential future dilution to existing shareholders. The securities were sold unregistered under Section 4(a)(2) and Rule 506 exemptions, meaning they cannot be resold in the U.S. without registration or an exemption.
Key Facts for Investor Verification
- Verify the exact closing date and net proceeds after deducting the 8% placement fee and $50,000 expense reimbursement.
- Confirm the status of the acquisition of Family Beginnings, P.C., and whether the full $375,000 allocated for the deal was utilized.
- Review the specific terms of the "Variable Rate Transaction" restriction to understand limitations on future financing flexibility.
- Monitor the filing of the Registration Statement required under the Registration Rights Agreement for the resale of the new securities.
- Assess the impact of the 4,733,728 Common Warrants and 118,343 Placement Agent Warrants on future earnings per share if exercised.